Diagnostic accuracy of ELISA and xMAP
technology for analysis of amyloid beta(42) and tau proteins.
The training is still based on the three phases of competition, cooperation, and adaptation but in SSSOM the algorithm differs from the USOM one, since the fused similarity measure is based on weighted combination distances between an object (vector) [[bar.X].sub.n] and all units in the X map (S([bar.X], Xmap
)) and the distances between the corresponding output object [y.sub.n] and the units in the Y map (S([bar.Y], Ymap)).
The concentrations of the serum cytokines (IFN-[gamma], TNF-[alpha], IL-2, IL-4, IL-6, IL-10, IL-9, and IL-17) were determined by xMAP
multiplex technology  on the Luminex 100 system (Luminex, Austin, TX, USA), using a Human Premixed Multi-Analyte Kit (R&D Systems, Inc., Minneapolis, USA), and further analyzed using Bioplex Manager Software (Bio-Rad Life Sciences, CA, USA).
(33) developed broad-spectrum HPV typing bead-based xMAP
Luminex suspension arrays, which are able to detect and differentiate 23 and 19 HPV types, respectively, that are most frequently found in common warts, including HPV2, HPV27, and HPV57.
Luminex aims to transform global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilising xMAP
open-architecture multi-analyte platform, MultiCode real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers.
Its proprietary technologies consist of xMAP
technology, xTAG and MultiCode technology.
Results were obtained using the high precision machine Megapix[R] (Luminex Corporation xMAP
Technology; Toronto, ON, Canada).
Identification of genotypically diverse Cryptococcus neoformans and Cryptococcus gattii isolates by Luminex xMAP
* Luminex Corporation's xMAP
MultiFLEX Zika RNA Assay
Based on Luminex xMAP
Platform, Creative Biolabs also provides custom multiplex assay services.
3) Microarray To develop a multi-test for serological sorting of all blood donated in the country by creating a new technology denominated XMAP
, to replace the current technology called ELISA.
To detect IgG seroresponses against the major capsid protein VP1 of HPyV9, we performed an antibody-binding assay using Luminex xMAP
technology (30), as described (26).